Navigation Links
Oncology Industry Veteran, Joe Baffone, Joins onPoint Oncology, LLC.
Date:1/19/2010

onPoint Oncology, LLC., a full service healthcare data solutions and reimbursement analytics firm, is proud to announce that Joe Baffone, an 18-year oncology executive with Sanofi-Aventis has joined onPoint Oncology LLC.

Hudson, Ohio (PRWEB) January 19, 2010 -- onPoint Oncology, LLC., a full service healthcare data solutions and reimbursement analytics firm, is proud to announce that Joe Baffone, an 18-year oncology executive with Sanofi-Aventis has joined onPoint Oncology LLC. "Joe rounds out our stellar management team with his strong background in oncology managed markets," said Tracy Lewis (President of onPoint), "We now have every facet in the oncology business covered. This range of expertise brings great value to our rapidly growing list of clients who need ground-breaking and creative project leadership in this dynamic environment."

"onPoint Oncology’s existing work to create novel products for their clients was my primary motivation," said Joe Baffone, "along with the opportunity to be part of the development, implementation and execution of innovative solutions in this dynamic market."

Joe Baffone has joined onPoint from Sanofi Aventis, where his background is steeped in sales, sales training, sales leadership, reimbursement, account management, national accounts. Particularly appealing for onPoint was his recent body of work with and on oncology managed market strategy. Mr. Baffone conceptualized, developed and led a non-traditional account management team responsible for working with commercial payers and oncology providers. His responsibilities included areas such as pathways, contracting and commercialization of new products.

"He shares

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
2. ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration
3. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
4. U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors
5. US Oncology to Report 2007 Third Quarter Earnings Results
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
8. Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals
9. Accuray Announces Four New Products at Nations Leading Radiation Oncology Meeting
10. Debiopharm and NanoCarrier Sign License and Supply Agreement for Dach-Platin Polymeric Micelle in Oncology
11. National Autism Association and Deirdre Imus Environmental Center for Pediatric Oncology Announce National Greening Your School Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... August 30, 2014 Market Research ... 2009-2019 is a professional and in-depth market survey ... report firstly reviews the basic information of Lab ... The report then explores global and China’s top ... capacity, production value, and market share etc. , ...
(Date:8/30/2014)... Serving contented clients since inception, #1 web design ... is now offering discount for Labor Day on all ... putting forward the best of web development technology before ... of professionals and web developers and designers has expertise ... critical issues of web development and can develop websites ...
(Date:8/30/2014)... York (PRWEB) August 30, 2014 ... transvaginal mesh lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ) filed against ... to sever four cases selected for one of ... issued on August 18, 2014, U.S. District Judge ... West Virginia disagrees with Boston Scientific’s contention that ...
(Date:8/30/2014)... 2014: Transvenous lead extraction (TLE) is clinically successful in ... the European Lead Extraction ConTRolled (ELECTRa) registry presented for ... Dr Maria Grazia Bongiorni, chair of the registry,s executive ... implantable electronic devices (CIED) implant procedures has grown in ... complications has increased and leads are often the cause. ...
(Date:8/30/2014)... In today’s world, a good night’s sleep ... Snoring and sleep apnea (a medical problem where the ... and their bed partners of the rest they need ... the population snores and 20 million people in the ... 10% have been diagnosed and treated; and of those ...
Breaking Medicine News(10 mins):Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Profit By Outsourcing Offering Discount for Labor Day on all Web Development Services 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:Transvenous lead extraction clinically successful in 98 percent of cases 2Health News:Transvenous lead extraction clinically successful in 98 percent of cases 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3
... German . Tafamidis meglumine (trade name: Vyndaqel) ... in adults. This rare disorder ("orphan disease") is caused by a ... that tafamidis is supposed to delay. According to 35a SGB ... if a drug for a rare disease - known as an ...
... Boston, MA New Harvard School of Public Health (HSPH) ... tool in detecting early breast cancersmay in fact lead to ... have proved harmless. Based on a study of women in ... breast cancer cases are overdiagnosed. The study appears in ...
... HealthDay Reporter , WEDNESDAY, April 4 (HealthDay News) ... called flavonoids, such as berries, apples, tea and red wine, ... 40 percent, new research suggests. For women, however, a ... least several servings of berries a week, according to ...
... Dotinga HealthDay Reporter , WEDNESDAY, April 4 (HealthDay ... HIV vaccine failed to protect most people who received it, ... vaccine efforts. Scientists believe an HIV vaccine, designed to ... several years away. Tests of experimental vaccines have largely been ...
... of scientists, engineers and physicians from Brigham and ... Medical School (HMS), Massachusetts Institute of Technology (MIT), ... State University Karmanos Cancer Institute, and Weill Cornell ... first-in-class targeted cancer drug called BIND-014 in treating ...
... , WEDNESDAY, April 4 (HealthDay News) -- Nine physician specialty ... they believe are often overused or unnecessary, to help doctors ... came up with a list with five tests or procedures ... part of the ABIM Foundation,s Choosing Wisely campaign. ...
Cached Medicine News:Health News:Tafamidis: Approval denotes proven added benefit 2Health News:Routine mammograms may result in significant overdiagnosis of invasive breast cancer 2Health News:Berries, Tea May Cut Men's Odds for Parkinson's: Study 2Health News:Berries, Tea May Cut Men's Odds for Parkinson's: Study 3Health News:From a Failed Vaccine, New Insights Into Fighting HIV 2Health News:First targeted nanomedicine to enter human clinical studies 2Health News:First targeted nanomedicine to enter human clinical studies 3Health News:First targeted nanomedicine to enter human clinical studies 4Health News:Physician Groups Call for Fewer Medical Tests 2
(Date:8/29/2014)... /PRNewswire-iReach/ -- ChemImage will present a workshop focused on ... Forensic Science Society,s 22 nd International Symposium ... Australia .  Forensic Scientists will be in ... imaging can bring to examination procedures. ... Product Development at ChemImage, will host a workshop ...
(Date:8/29/2014)... and MENLO PARK, Calif. , ... Inc. (OTCQB: DMPI) ("DelMar" "the Company") today announced ... statements.  The Company recently changed its fiscal year end ... to list its common stock on a national securities ... financial statements as filed with the United States Securities ...
(Date:8/28/2014)... Aug. 28, 2014 Reportlinker.com announces that ... its catalogue: North America Aesthetic Lasers ... http://www.reportlinker.com/p02343466/North-America-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html North ... to 2020 Summary GlobalData,s new report, ... Outlook to 2020", provides key market data on ...
Breaking Medicine Technology:ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16
... , , TROY, Mich., Jan. 8 ... for the fourth quarter and fiscal year ended November 30, 2009 ... In conjunction with releasing its financial results, the Company will ... a.m. (ET) the same day. , On the ...
... , , PRINCETON, N.J., ... management will present at the 28th Annual JPMorgan Healthcare Conference being ... Francis in San Francisco, CA. Schaefer Price, Pharmasset,s President and Chief ... conference on Thursday, January 14, 2010 at 2:00 PM (PT). , ...
Cached Medicine Technology:Somanetics Corporation to Release Fourth Quarter and Fiscal 2009 Financial Results and Host Conference Call January 21, 2010 2Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference 2Pharmasset to Present at the 28th Annual JPMorgan Healthcare Conference 3
... eNclose Anastomosis Assist Device ... obviate the need for ... aorta. The enclose device ... with a stable, bloodless ...
15mm Open Blades, 30mm Maximum Blade Spread; in Titanium....
7mm Cross Hairs; Available in 4.5mm to 7.0mm in 0.5mm increments; Ring depth available from 2 to 4mm in 0.5mm increments.; in stainless steel....
2.0mm Rounded Tip, 12mm From Tip to Bend Gently Curved, 15mm Shaft; In Titanium...
Medicine Products: